Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,04 USD | -4,01% | -10,88% | -27,91% |
14:09 | Regenxbio benoemt Curran Simpson tot president, CEO | MT |
14:00 | Transcript : REGENXBIO Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:00 AM |
Omzet 2024 * | 98,44 mln. 90,9 mln. | Omzet 2025 * | 245 mln. 226 mln. | Marktkapitalisatie | 669 mln. 618 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -231 mln. -213 mln. | Nettowinst (verlies) 2025 * | -113 mln. -104 mln. | EV/omzet 2024 * | 5,76 x |
Nettoliquiditeiten 2024 * | 102 mln. 93,85 mln. | Nettoliquiditeiten 2025 * | 157 mln. 145 mln. | EV/omzet 2025 * | 2,09 x |
K/w-verhouding 2024 * |
-2,74
x | K/w-verhouding 2025 * |
-7,75
x | Werknemers | 344 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,81% |
Recentste transcriptie over REGENXBIO Inc.
1 dag | -3,87% | ||
1 week | -10,88% | ||
Lopende maand | -9,83% | ||
1 maand | -17,79% | ||
3 maanden | -41,13% | ||
6 maanden | -32,39% | ||
Lopend jaar | -27,91% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Kenneth Mills
FOU | Founder | 49 | 16-07-08 |
Vit Vasista
DFI | Director of Finance/CFO | 56 | 01-08-09 |
Chief Tech/Sci/R&D Officer | - | 01-11-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 03-09-21 |
David Stump
BRD | Director/Board Member | 74 | 15-10-15 |
Director/Board Member | 71 | 01-05-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.76% | 15 M€ | -3,67% | ||
0.25% | 26 M€ | -2,88% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
12-06-24 | 13,04 | -3,97% | 431 526 |
11-06-24 | 13,58 | -0,95% | 454 021 |
10-06-24 | 13,71 | -2,63% | 674 362 |
07-06-24 | 14,08 | +2,33% | 330 010 |
06-06-24 | 13,76 | -5,23% | 397 412 |
uitgestelde koers Nasdaq, 12 juni 2024 om 20:28 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,91% | 669 mln. | |
+17,04% | 124 mld. | |
+16,41% | 109 mld. | |
-6,70% | 23,84 mld. | |
+1,98% | 22,42 mld. | |
-14,29% | 17,5 mld. | |
-8,03% | 16,61 mld. | |
-37,63% | 16,43 mld. | |
+2,22% | 13,4 mld. | |
+24,25% | 11,47 mld. |